Establishment Labs Holdings Stock Working Capital
| ESTA Stock | USD 48.47 0.07 0.14% |
Establishment Labs Holdings fundamentals help investors to digest information that contributes to Establishment Labs' financial success or failures. It also enables traders to predict the movement of Establishment Stock. The fundamental analysis module provides a way to measure Establishment Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Establishment Labs stock.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 117.8 M | 87.1 M | |
| Change In Working Capital | -33.4 M | -31.8 M | |
| Working Capital | 0.00 | 0.00 |
Establishment | Working Capital |
Establishment Labs Holdings Company Working Capital Analysis
Establishment Labs' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Establishment Labs Working Capital | 117.75 M |
Most of Establishment Labs' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Establishment Labs Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Establishment Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for Establishment Labs is extremely important. It helps to project a fair market value of Establishment Stock properly, considering its historical fundamentals such as Working Capital. Since Establishment Labs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Establishment Labs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Establishment Labs' interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Establishment Capital Surpluse
Capital Surpluse |
|
According to the company's disclosures, Establishment Labs Holdings has a Working Capital of 117.75 M. This is 72.34% lower than that of the Health Care Equipment & Supplies sector and 91.35% lower than that of the Health Care industry. The working capital for all United States stocks is 92.03% higher than that of the company.
Establishment Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Establishment Labs' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Establishment Labs could also be used in its relative valuation, which is a method of valuing Establishment Labs by comparing valuation metrics of similar companies.Establishment Labs is currently under evaluation in working capital category among related companies.
Establishment Labs Current Valuation Drivers
We derive many important indicators used in calculating different scores of Establishment Labs from analyzing Establishment Labs' financial statements. These drivers represent accounts that assess Establishment Labs' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Establishment Labs' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 568.2M | 877.6M | 1.6B | 1.6B | 662.8M | 706.4M | |
| Enterprise Value | 578.7M | 844.9M | 1.6B | 1.7B | 815.0M | 732.2M |
Establishment Fundamentals
| Return On Equity | -15.38 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.48) % | ||||
| Operating Margin | (0.70) % | ||||
| Current Valuation | 1.47 B | ||||
| Shares Outstanding | 27.46 M | ||||
| Shares Owned By Insiders | 11.44 % | ||||
| Shares Owned By Institutions | 78.08 % | ||||
| Number Of Shares Shorted | 4.89 M | ||||
| Price To Earning | (20.11) X | ||||
| Price To Book | 75.06 X | ||||
| Price To Sales | 8.36 X | ||||
| Revenue | 165.15 M | ||||
| Gross Profit | 106.59 M | ||||
| EBITDA | (60.14 M) | ||||
| Net Income | (78.5 M) | ||||
| Cash And Equivalents | 65.35 M | ||||
| Cash Per Share | 2.68 X | ||||
| Total Debt | 192.22 M | ||||
| Current Ratio | 4.27 X | ||||
| Book Value Per Share | 0.70 X | ||||
| Cash Flow From Operations | (87.82 M) | ||||
| Short Ratio | 14.71 X | ||||
| Earnings Per Share | (3.07) X | ||||
| Target Price | 60.33 | ||||
| Number Of Employees | 908 | ||||
| Beta | 1.25 | ||||
| Market Capitalization | 1.33 B | ||||
| Total Asset | 268.64 M | ||||
| Retained Earnings | (360.1 M) | ||||
| Working Capital | 117.75 M | ||||
| Current Asset | 60.91 M | ||||
| Current Liabilities | 45.78 M | ||||
| Net Asset | 268.64 M |
About Establishment Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Establishment Labs Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Establishment Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Establishment Labs Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Establishment Labs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Establishment Labs' short interest history, or implied volatility extrapolated from Establishment Labs options trading.
Pair Trading with Establishment Labs
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Establishment Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Establishment Labs will appreciate offsetting losses from the drop in the long position's value.Moving against Establishment Stock
| 0.8 | GH | Guardant Health Financial Report 14th of May 2024 | PairCorr |
| 0.69 | DNA | Ginkgo Bioworks Holdings Financial Report 8th of May 2024 | PairCorr |
| 0.53 | IDXX | IDEXX Laboratories Financial Report 7th of May 2024 | PairCorr |
| 0.46 | CTSO | Cytosorbents Crp Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Establishment Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Establishment Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Establishment Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Establishment Labs Holdings to buy it.
The correlation of Establishment Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Establishment Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Establishment Labs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Establishment Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Establishment Labs Piotroski F Score and Establishment Labs Altman Z Score analysis. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Establishment Stock analysis
When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Establishment Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.07) | Revenue Per Share 6.451 | Quarterly Revenue Growth (0.28) | Return On Assets (0.17) | Return On Equity (15.38) |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.